Media presence is a key part of making society aware of developments in biotechnology and its benefits. AseBio makes this platform available to members so they can share their press releases, alongside those the association posts regularly. If you are a journalist interested in learning more about the biotechnology sector, contact us at AseBio.
The Spanish government has announced the public grants corresponding to the State Program for research, development and innovation call — geared towards societal challenges and called “Collaboration Challenges of the year 2019”. These are instruments to help meet the needs of the Spanish Science, Technology and Innovation System and its main agents.
One of the approved proposals has been the project GLIOPROG561 (RTC2019-007399-1) led by our company in collaboration with the CIBIR- Biomedical Research Center of La Rioja (Fundación Rioja Salud) and the University of the Balearic Islands (UIB), whose objective is the “Identification and validation of prognosis response biomarkers in treatment with the LAM561 molecule in patients with glioma and evaluation of the pharmacological activity of its main metabolite”.
Will also present at Jefferies 2020 Virtual London Healthcare Conference. CEO to participate in a Borderline Personality Disorder Day panel
Clinical Trial Application approved by Spanish Drug Agency
At Roche, Dr. Hoffmann was Head of Discovery Chemistry and Head of the Roche Postdoc Fellowship Program. Subsequently he served as Chief Scientific Officer and Executive VP at Zealand Pharma, Chief Scientific Officer of British Silence Therapeutics
In just over a year of history, the company has established itself as a leading driver in the biomedical innovation and entrepreneurship scene
Oryzon Genomics reported financial results for the third quarter of 2020 and provided an update on recent developments
New investors include 4BIO Capital, UPMC Enterprises, Jeito Capital and Ysios Capital
“New technologies are a key element of digital transformation in the healthcare sector", Ricard Sagués, Business Development & Marketing Director at Asphalion
The OSD is an annual initiative whereby the company's employees devote part of their working hours to carry out activities that can have a positive impact on society